Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04135365 · ClinicalTrials.gov registry record

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

A clinical trial, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
12
Enrollment target

NCT04135365 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04135365 has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
12 participants
Enrollment target

Study Summary

The proposed project will assess hypothesized risk factors (age of onset, Diabetic ketoacidosis (DKA) at presentation and glycemic control), as well as potentially modifiable protective factors (child sleep quality, caregiver distress, and use of diabetes devices). In addition, the study will optimize imaging protocols and processing tools to allow for harmonization of neuroimaging data across sites and scanners for the most robust analysis.

Interventions

  • BEHAVIORAL neurocognitive assessment
  • BEHAVIORAL neuroimaging assessment

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2021-01-18
Est. Completion 2022-10-31

What the Registry Record Tells You About NCT04135365

The ClinicalTrials.gov registry entry for NCT04135365 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which neurocognitive assessment is the first listed.

NCT04135365 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04135365 about?

NCT04135365 is a clinical study titled "Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study". The proposed project will assess hypothesized risk factors (age of onset, Diabetic ketoacidosis (DKA) at presentation and glycemic control), as well as potentially modifiable protective factors (child sleep quality, caregiver distress, and use of diabetes devices). In addition, the study will optimi...

What is the current status of trial NCT04135365?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2021-01-18. Estimated completion is 2022-10-31.

What interventions are being tested in trial NCT04135365?

The interventions under investigation include: neurocognitive assessment (BEHAVIORAL), neuroimaging assessment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04135365?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.